Report Categories
View AllRecent Articles
View All
Why Lyft LYFT deserves a spot on your radar now Steady Decline 20260507
Ready RCD Stock MACD Signal Nudges Up 20260418
Oxford OXLC Stock Why Efficiency Gains Trend Strengthens 20260415
TW Tradeweb Markets posts narrow Q1 2026 EPS miss shares rise 079 percent on upbeat investor sentiment
What derivatives exposure ParkerHannifin Corporation PH Momentum Fading 20260429
What Wheels Up UP does that creates lasting value Trend Strengthens 20260508
SSACR SPACSphere posts quarterly earnings results with no publicly shared core financial or operational metrics
Grupo OMAB Q1 2026 Results Fall Short EPS 319 Revenue NA
Marc Jacobs Leaves LVMH Portfolio After Three Decades Remains Creative Director
Accuray ARAY Q1 2026 Disappoints EPS 009 Below 005 Views
Tokenization Will Allow Investors to Shop for Yield Says Strategys Michael Saylor
USChina Trade Rifts Persist After APEC Three Key Indicators
AI Looms Over Japans NearRecord Employment Rate for New Graduates
Michael Burry Warns SECs Blockchain Stock Trading Plan Could Spell Nightmare for Investors
Wipro Sets June 5 Record Date for 15000 Crore Share Buyback Largest in Company History
Page Industries Posts 14 Revenue Growth in Q4 FY25 Driven by Operations and Sales Volume
Trumps Q1 2026 Stock Trades Disclose Significant Activity in Big Tech Potential Gains
HLI Q1 2026 Earnings EPS Misses Estimates Stock Declines 24
CFR Q1 2026 Earnings Earnings Beat Driven by Strong Core Performance
DocGo Q1 2026 Earnings EPS Misses Estimates but Shares Rise
Bandwidth Inc Q1 2026 Earnings EPS Beats Estimates by 22 as Stock Rises Nearly 5
Exodus Movement Inc EXOD Q1 2026 Earnings Deep Loss Misses Estimates Stock Rises 176
KT Q1 2026 Earnings EPS Misses Estimates Amid Operational Challenges
DRDGOLD DRD Extends Gains on Elevated Gold Sentiment Resistance Test Ahead
Vine Hill Capital Corp II VHCP Nudges Higher as Shares Trade Near Trust Value
Aclaris Therapeutics ACRS Edges Higher Testing Resistance After Modest Uptick
Immutep IMMP Shares Slide 66 as Biotech Stock Tests Key Support at 043
Estrella Immunopharma ESLA Slips 26 as Stock Tests Key Support Near 106